Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Clinical trial NCT00430781 · COMPLETED

Trial details

NCT number: NCT00430781
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Uterine Cervix Metastatic Cervical Cancer

Start date: 2006-11-01
Primary completion: 2008-07-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.